Compare PATK & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PATK | GPCR |
|---|---|---|
| Founded | 1959 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.8B |
| IPO Year | 1994 | 2023 |
| Metric | PATK | GPCR |
|---|---|---|
| Price | $94.83 | $50.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 12 |
| Target Price | ★ $122.75 | $103.17 |
| AVG Volume (30 Days) | 366.9K | ★ 805.8K |
| Earning Date | 04-30-2026 | 05-08-2026 |
| Dividend Yield | ★ 2.02% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.10 | N/A |
| Revenue | ★ $29,000,000.00 | N/A |
| Revenue This Year | $5.78 | N/A |
| Revenue Next Year | $6.51 | N/A |
| P/E Ratio | $84.25 | ★ N/A |
| Revenue Growth | ★ 262.50 | N/A |
| 52 Week Low | $82.35 | $15.80 |
| 52 Week High | $148.50 | $94.90 |
| Indicator | PATK | GPCR |
|---|---|---|
| Relative Strength Index (RSI) | 59.78 | 74.02 |
| Support Level | $83.16 | $36.11 |
| Resistance Level | $97.19 | $57.23 |
| Average True Range (ATR) | 3.32 | 2.29 |
| MACD | 1.23 | 1.00 |
| Stochastic Oscillator | 95.40 | 98.67 |
Patrick Industries Inc is a component solutions provider for the recreational vehicle (RV), marine, powersports, manufactured housing (MH), and various industrial markets, including single and multi-family housing, hospitality, institutional, and commercial markets. The company operates within two reportable segments, Manufacturing and Distribution. The majority of its revenue is generated from the Manufacturing segment, which offers laminated products utilized to produce furniture, shelving, walls, and countertops; fabricated aluminum products; cabinet products, doors, components, and custom cabinetry; interior passage doors and baggage doors; RV and marine furniture, etc. Geographically, the company mainly operates in the United States, with a small presence in Mexico, China, and Canada.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.